Patent · US Expired

Immunoassays for prostate specific antigen

US5599677A · kind A · utility

110Cited by
5References
33Claims
0Family size

Assignee

Inventors

Key dates

Filing dateDec 29, 1993
Grant dateFeb 4, 1997
Priority date
Expiry dateDec 29, 2013

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY10S436/813
  • WIPO fieldMeasurement
  • WIPO sectorInstruments

Abstract

The present invention relates to the field of cancer immunoassay. Specifically, a new immunoassay method for prostate specific antigen (PSA) is presented. Also presented is a complex which resembles a complex of PSA and .alpha.-antichymotrypsin (ACT) that can be used as a calibrator or control in an immunoassay for PSA. Further presented is a method for fractionating polyclonal antibodies, to PSA, into those which bind epitopes that are masked by the binding of PSA to ACT and those which do not bind such epitopes.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.